Peetz Christopher sold MIRM
June 1, 2026 · Form 4 insider transaction
Peetz Christopher sold 1,973 shares of Mirum Pharmaceuticals, Inc. at $97.56 per share, a transaction worth $192.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,973
Price
$97.56
Total value
$192.5K
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after196,213
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026.; The weighted average sale price for the transaction reported was $97.56, and the range of prices were between $96.98 and $97.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.